PDLIM7 and neoplasm: Overall, IHC evaluation confirmed a non-canonical latency associated program with the expression of some proteins characterizing latency II (i.e. LMP-1 in 2/26 and LMP-2A in 17/26 of the cases); however, there was heterogeneity in the intensity of protein staining and in the proportion of positive tumor cells.